Technology

Creating Discovery Sources

Continuous expansion of our Multidimensional PepMetics^® Compound Library and Proprietary Synthesis Platform to Advance PPI Drug Discovery

Designing with Precision

A Next-Generation Molecular Design Platform Integrating PepMetics^®-Specific In Silico Drug Discovery and AI to Accelerate PPI Programs

Selecting Winning Targets

Focused Approach to Identifying High-Probability PPI Drug Targets by Leveraging the Unique Characteristics of PepMetics^® Chemistry

Identifying Compounds with Therapeutic Value

An Integrated Evaluation Platform to Efficiently Assess PepMetics^® Library Compounds and Generate Promising Leads Based on Mechanism of Action and Binding Modes